germline brca1/2: a new subset of breast cancer
Published 6 years ago • 151 plays • Length 5:14Download video MP4
Download video MP3
Similar videos
-
6:35
treatment options for patients with brca1/2
-
2:21
a study of talazoparib in somatic brca1/2 mutant mbc identified by cfdna or tumor tissue genotyping
-
5:29
implications for germline brca testing in breast cancer
-
6:58
detecting somatic brca1/2 mutations in ovarian cancer
-
8:37
brca1 and brca2 mutations & cancer (types of cancer, and who’s most at risk)
-
0:25
germline brca1 & brca2 mutation test | dr. vivek belathur | precision oncology clinics
-
4:10
brca1 and brca2 genes and hereditary breast cancers
-
7:48
hologic ceo steve macmillan on breast cancer detection, future of ai-powered diagnostics
-
30:44
genetic testing and management of breast cancer susceptibility germline mutations
-
28:57
2021 force | hereditary cancer | cancer risks, screening & prevention for brca1 or brca2 mutations
-
10:52
understanding brca1 and brca2: what these mutations mean for breast cancer risk
-
7:04
testing for brca germline mutations in the clinic and the mechanism of action of parp inhibitors
-
3:39
zen-3694, a novel bet inhibitor, in tnbc without germline brca1/2 mutations
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
1:22
brca1/2 gene test | risk of hereditary breast and ovarian cancer | medgenome
-
3:31
brca1 and brca2 genetic testing panel overview | ambry genetics
-
49:37
updates on brca1 vuss
-
1:43
dr. lori pierce on the impact of brca1/2 mutations on breast cancer treatment decisions
-
23:25
gene expression algorithm for prioritizing treatment options in brca1/2 carriers with breast cancer